281 related articles for article (PubMed ID: 6210347)
21. Idiotype network theory and its implications in anti-tumor immunity.
Bona CA
Prog Clin Biol Res; 1989; 288():215-21. PubMed ID: 2470108
[No Abstract] [Full Text] [Related]
22. Molecular basis of antigen mimicry by an anti-idiotope.
Fields BA; Goldbaum FA; Ysern X; Poljak RJ; Mariuzza RA
Nature; 1995 Apr; 374(6524):739-42. PubMed ID: 7536303
[TBL] [Abstract][Full Text] [Related]
23. Idiotypic control of the immune response.
Valderrama R; Eggers AE; Revan S; Moomjy M; Frost M; Pipia P; Di Paola M
J Neuroimmunol; 1988 Dec; 20(2-3):269-76. PubMed ID: 2461958
[TBL] [Abstract][Full Text] [Related]
24. Idiotypic-antiidiotypic interactions in man.
Geha RS
Ric Clin Lab; 1985; 15(1):1-8. PubMed ID: 3158061
[TBL] [Abstract][Full Text] [Related]
25. Antiidiotypic networks.
Hiernaux J
Fed Proc; 1981 Apr; 40(5):1484-8. PubMed ID: 6452292
[TBL] [Abstract][Full Text] [Related]
26. Influence of subclass-specific anti-idiotypic antibodies on the kinetics of the immune response to BCG.
Daus H; Hammer HJ; Rajki K; Mauch H
Immunology; 1984 Aug; 52(4):697-702. PubMed ID: 6611300
[TBL] [Abstract][Full Text] [Related]
27. Idiotypes in autoimmune diseases.
Colvin RB; Olson KA
Concepts Immunopathol; 1985; 1():133-72. PubMed ID: 3916401
[No Abstract] [Full Text] [Related]
28. Autobodies, epibodies and homobodies: role in autoimmunity.
Kang CY; Kohler H
Concepts Immunopathol; 1986; 3():225-32. PubMed ID: 2439205
[No Abstract] [Full Text] [Related]
29. Cellular handling of a monoclonal anti-idiotypic antibody in IgA-producing MOPC 315 mouse myeloma cells.
Marks A; Baumal R; Ahmad A
Anticancer Res; 1984; 4(3):183-8. PubMed ID: 6331799
[TBL] [Abstract][Full Text] [Related]
30. Antiidiotypic responses in the suppression of allograft rejection.
Batchelor JR
Transplant Proc; 1989 Feb; 21(1 Pt 1):57-8. PubMed ID: 2650201
[No Abstract] [Full Text] [Related]
31. Antiidiotype antibody therapy of B-cell lymphoma.
Brown SL; Miller RA; Levy R
Semin Oncol; 1989 Jun; 16(3):199-210. PubMed ID: 2658083
[No Abstract] [Full Text] [Related]
32. In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives.
Erlandsson A; Eriksson D; Johansson L; Riklund K; Stigbrand T; Sundström BE
Mol Immunol; 2006 Feb; 43(6):599-606. PubMed ID: 15978666
[TBL] [Abstract][Full Text] [Related]
33. Anti-idiotypic reagents.
Davie JM
J Immunol Methods; 1980; 38(1-2):1-7. PubMed ID: 6161191
[No Abstract] [Full Text] [Related]
34. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
Foon KA
N Engl J Med; 1982 Sep; 307(11):686-7. PubMed ID: 6981064
[No Abstract] [Full Text] [Related]
35. Anti-idiotypic regulatory responses induced by vaccination with DNA encoding murine TCR Valpha5 and Vbeta2.
Wu Y; Zhang Y; Xu X; Lv P; Gao X
Cell Mol Immunol; 2007 Aug; 4(4):287-93. PubMed ID: 17764619
[TBL] [Abstract][Full Text] [Related]
36. Idiotypes, anti-idiotypes, and autoimmunity.
Rico MJ; Hall RP
J Am Acad Dermatol; 1988 Sep; 19(3):579-85. PubMed ID: 3049705
[TBL] [Abstract][Full Text] [Related]
37. Vaccines in lymphoma.
Levy R
Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215
[No Abstract] [Full Text] [Related]
38. Expression and function of idiotypes of lymphocytes.
Eichmann K
Adv Immunol; 1978; 26():195-254. PubMed ID: 80953
[No Abstract] [Full Text] [Related]
39. Structural and biological properties of a monoclonal auto-anti-(anti-idiotype) antibody.
Pollok BA; Bhown AS; Kearney JF
Nature; 1982 Sep; 299(5882):447-9. PubMed ID: 6981775
[No Abstract] [Full Text] [Related]
40. Prediction of humoral immune responses to HLA through antiidiotypic antibody studies.
Reed E; McManus P; Ho E; Benvenisty A; Hardy M; McCabe R; Brensilver J; King DW; Suciu-Foca N
Transplant Proc; 1989 Feb; 21(1 Pt 1):708-10. PubMed ID: 2650235
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
